Wolverine Trading
QNCX icon

Wolverine Trading’s Quince Therapeutics QNCX Stock Holding History

Wolverine Trading’s Portfolio QNCX Stock Details QNCX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-64
Closed -$19.8K – 6063
2025
Q2 		$19.8K Buy
+64
New +$14.6K ﹤0.01% 4469
2025
Q1 		– Sell
-107
Closed -$39.6K – 5610
2024
Q4 		$39.6K Buy
+107
New +$32.1K ﹤0.01% 5024
2023
Q3 		– Sell
-88
Closed -$26.5K – 4974
2023
Q2 		$26.5K Sell
88
-58
-40% -$18.1K ﹤0.01% 4070
2023
Q1 		$45K Buy
+146
New +$28.6K ﹤0.01% 3859
2022
Q3 		– Sell
-51
Closed -$23K – 5192
2022
Q2 		$23K Sell
51
-131
-72% -$92.6K ﹤0.01% 4213
2022
Q1 		$224K Buy
182
+15
+9% +$20.4K ﹤0.01% 4267
2021
Q4 		$427K Buy
+167
New +$1.02M ﹤0.01% 3669

Other funds holding QNCX

NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
IC
IEQ Capital Foster City, California $21.5B AUM 75.26% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
AC
Almitas Capital Santa Monica, California $443M AUM 42.36% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return